Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05741957
Other study ID # HKU-NFF
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date March 2, 2023
Est. completion date December 31, 2026

Study information

Verified date May 2023
Source The University of Hong Kong
Contact Parco M. Siu, PhD
Phone 2831 5262
Email pmsiu@hku.hk
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study aims to examine the comparative effectiveness of different exercise frequencies (once-a-week vs. thrice-a-week) for reducing liver fat in centrally obese adults with non-alcoholic fatty liver disease (NAFLD), with weekly exercise volumes aligned with the World Health Organization's physical activity recommendations.


Description:

This study is a three-arm randomized controlled trial. Participants will be randomly allocated to the once-a-week exercise group, thrice-a-week exercise group, or usual care control group. The exercise intervention groups will receive once-a-week or thrice-a-week exercise (with matched weekly exercise volumes). The usual care control group will receive general health education. All interventions will last for 4 months. Outcome measures will be examined at baseline, 4 months (post-intervention), and 10 months (6-month follow-up).


Recruitment information / eligibility

Status Recruiting
Enrollment 300
Est. completion date December 31, 2026
Est. primary completion date June 30, 2026
Accepts healthy volunteers No
Gender All
Age group 18 Years to 69 Years
Eligibility Inclusion Criteria: 1. Cantonese, Mandarin, or English speaking Chinese; 2. Aged 18-69; 3. Male or female; 4. Centrally obese according to the Asian-specific cut-off (waist circumference =90 cm for males; =80 cm for females) and with BMI =23; 5. With NAFLD (defined as >5% intrahepatic triglycerides assessed by 1H-MRS); 6. Willing to participate in exercise training to improve NAFLD. Exclusion Criteria: 1. Regular exercise training (>3 sessions of >60 min of moderate-intensity exercise training weekly) in the past 6 months; 2. Medical history of cardiovascular disease, chronic pulmonary or kidney disease, heart failure, cancer, and/or liver disease except NAFLD; 3. Somatic conditions that limit exercise participation (e.g., limb loss); 4. Impaired mobility due to chronic disease (e.g., chronic arthritis/osteoarthritis, neurological, musculoskeletal, and autoimmune diseases); 5. Daily smoking habit; 6. Excess alcohol consumption (daily =20 g of alcohol for men and =10 g for women) in the past 1 year; 7. Consumption of certain drugs (e.g., tamoxifen and estrogen) known to be secondary causes of steatosis; 8. Surgery, therapy, or medication for obesity or weight loss in the past 6 months (e.g., gastric bypass, gastric band, sleeve gastrectomy, gastric reduction duodenal switch, or dietitian-prescribed dietary program); 9. Physical changes that considerably affect body composition and weight (e.g., anorexia nervosa, bulimia nervosa, prolonged gastrointestinal and digestive disorders) during the study period.

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Once-a-week Exercise
Participants in this group will participate in a supervised treadmill exercise program delivered by certified fitness instructors. The prescribed program will involve one session weekly for 4 months, and the duration of vigorous-intensity treadmill exercise per session will be 75 min. Participants will exercise with an exercising heart rate at 6-7 metabolic equivalents (METs). Health information provided to the usual care control group will be made available to the participants in this group.
Thrice-a-week Exercise
Participants in this group will participate in a supervised treadmill exercise program delivered by certified fitness instructors. The prescribed program will involve three sessions weekly for 4 months, and the duration of vigorous-intensity treadmill exercise per session will be 25 min. Participants will exercise with an exercising heart rate at 6-7 METs. Health information provided to the usual care control group will be made available to the participants in this group.
Other:
Usual Care Control
Participants in this group will receive health education delivered by research personnel. This program will consist of eight two-hour bi-weekly sessions covering major health issues relating to general health and NAFLD, such as non-communicable diseases, infectious diseases, and a healthy lifestyle.

Locations

Country Name City State
Hong Kong LKS Faculty of Medicine Hong Kong

Sponsors (1)

Lead Sponsor Collaborator
The University of Hong Kong

Country where clinical trial is conducted

Hong Kong, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in Liver Fat Intrahepatic triglycerides will be assessed using proton magnetic resonance spectroscopy (1H-MRS) in a 3×3×3 cm voxel. Baseline and 4 months (post-intervention)
Secondary Change in Liver Fat Intrahepatic triglycerides will be assessed using 1H-MRS in a 3×3×3 cm voxel. Baseline and 10 months (follow-up)
Secondary Change in Abdominal Visceral Fat Abdominal visceral fat will be assessed using magnetic resonance imaging (MRI). Baseline, 4 months (post-intervention), and 10 months (follow-up)
Secondary Change in Body Fat Total body fat mass will be assessed using dual-energy x-ray absorptiometry (DXA). Baseline, 4 months (post-intervention), and 10 months (follow-up)
Secondary Change in Body Mass Index Weight and height will be assessed using a calibrated electronic digital weighing scale and a stadiometer, respectively. Baseline, 4 months (post-intervention), and 10 months (follow-up)
Secondary Change in Waist Circumference Waist circumference will be assessed using an inelastic measuring tape to the nearest 0.1 cm on bare skin. Baseline, 4 months (post-intervention), and 10 months (follow-up)
Secondary Change in Maximal Oxygen Consumption Maximal oxygen consumption will be assessed using the modified Bruce protocol. Baseline, 4 months (post-intervention), and 10 months (follow-up)
Secondary Change in Physical Component Summary Score of the 12-Item Short-Form Health Survey Physical health-related quality of life will be assessed using the Physical Component Summary scale of the 12-Item Short-Form Health Survey (SF-12). Scores on the scale range from 0 to 100, with higher scores indicating better physical health-related quality of life. Baseline, 4 months (post-intervention), and 10 months (follow-up)
Secondary Change in Mental Component Summary Score of the 12-Item Short-Form Health Survey Mental health-related quality of life will be assessed using the Mental Component Summary scale of the 12-Item Short-Form Health Survey (SF-12). Scores on the scale range from 0 to 100, with higher scores indicating better mental health-related quality of life. Baseline, 4 months (post-intervention), and 10 months (follow-up)
Secondary Number of Adverse Events Adverse events related or unrelated to the intervention will be assessed. Baseline, 4 months (post-intervention), and 10 months (follow-up)
See also
  Status Clinical Trial Phase
Recruiting NCT04243317 - Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults N/A
Recruiting NCT04101669 - EndoBarrier System Pivotal Trial(Rev E v2) N/A
Terminated NCT03772886 - Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball N/A
Completed NCT03640442 - Modified Ramped Position for Intubation of Obese Females. N/A
Completed NCT04506996 - Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2 N/A
Recruiting NCT06019832 - Analysis of Stem and Non-Stem Tibial Component N/A
Active, not recruiting NCT05891834 - Study of INV-202 in Patients With Obesity and Metabolic Syndrome Phase 2
Active, not recruiting NCT05275959 - Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI) N/A
Recruiting NCT04575194 - Study of the Cardiometabolic Effects of Obesity Pharmacotherapy Phase 4
Completed NCT04513769 - Nutritious Eating With Soul at Rare Variety Cafe N/A
Withdrawn NCT03042897 - Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer N/A
Completed NCT03644524 - Heat Therapy and Cardiometabolic Health in Obese Women N/A
Recruiting NCT05917873 - Metabolic Effects of Four-week Lactate-ketone Ester Supplementation N/A
Active, not recruiting NCT04353258 - Research Intervention to Support Healthy Eating and Exercise N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Recruiting NCT03227575 - Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control N/A
Completed NCT01870947 - Assisted Exercise in Obese Endometrial Cancer Patients N/A
Recruiting NCT05972564 - The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function Phase 1/Phase 2
Recruiting NCT06007404 - Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
Recruiting NCT05371496 - Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction Phase 2